⚕ GalenOps CRO console
← 714 (USA)

714-1195

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 714 (USA) (Dr. Clarke) · consented 2013-04-26
Adverse events
9
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

severe assessed 2026-08-18

Severe APPLICATION SITE ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-13 (study day 18.0); relationship: PROBABLE

severe assessed 2026-08-18

Severe APPLICATION SITE ERYTHEMA — outcome: RECOVERED/RESOLVED; onset 2013-05-13 (study day 18.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-17 (study day 22.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild DIARRHOEA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-12 (study day 17.0); relationship: REMOTE

mild assessed 2026-08-18

Mild DIARRHOEA — outcome: RECOVERED/RESOLVED; onset 2013-05-12 (study day 17.0); relationship: REMOTE

mild assessed 2026-08-18

Mild DYSURIA — outcome: RECOVERED/RESOLVED; onset 2013-07-25 (study day 91.0); relationship: REMOTE

moderate assessed 2026-08-18

Moderate HYPERHIDROSIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-12 (study day 17.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate HYPERHIDROSIS — outcome: RECOVERED/RESOLVED; onset 2013-05-12 (study day 17.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild SOMNOLENCE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-14 (study day 19.0); relationship: NONE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.